JAT 67m revenues fy192.5m net profitsecured supply chain after acquisition of plantthis significnalty reduces manufacturing costproviding significant synergiesall this for a market cap of 47mcompared to Industry peers this is a no brainer
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution
